Olczak S A, Greenwood R H, Hales C N
Horm Metab Res. 1986 Jan;18(1):38-41. doi: 10.1055/s-2007-1012220.
Insulin binding to monocytes and the counterregulatory hormone response to intravenous insulin was determined in six normal subjects and eight patients with non-insulin dependent diabetes mellitus (NIDDM), before and after seven days treatment with oral diazoxide. In the normal subjects diazoxide had no effect on insulin binding or sensitivity. In the patients with NIDDM diazoxide caused resistance to intravenous insulin with no change in the counterregulatory hormone response or in insulin binding to account for this. Diazoxide appears to cause post-receptor insulin resistance in NIDDM, and it may be a useful tool for studying post-receptor binding events.
在六名正常受试者和八名非胰岛素依赖型糖尿病(NIDDM)患者中,测定了静脉注射胰岛素前及口服二氮嗪七天治疗前后胰岛素与单核细胞的结合以及对静脉注射胰岛素的对抗调节激素反应。在正常受试者中,二氮嗪对胰岛素结合或敏感性无影响。在NIDDM患者中,二氮嗪导致对静脉注射胰岛素产生抵抗,但对抗调节激素反应或胰岛素结合无变化以解释此现象。二氮嗪似乎在NIDDM中引起受体后胰岛素抵抗,它可能是研究受体后结合事件的有用工具。